Lexicon Pharmaceuticals Inc. (LXRX) reported Loss for fourth quarter that decreased from the same period last year and beat the Street estimates.
The company's bottom line came in at -$33.77 million, or -$0.09 per share. This compares with -$49.76 million, or -$0.20 per share, last year.
Analysts on average had expected the company to earn -$0.12 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 3692.9% to $26.55 million from $0.70 million last year.
Lexicon Pharmaceuticals Inc. earnings at a glance (GAAP) :
-Earnings: -$33.77 Mln. vs. -$49.76 Mln. last year.
-EPS: -$0.09 vs. -$0.20 last year.
-Revenue: $26.55 Mln vs. $0.70 Mln last year.
For comments and feedback: editorial@rttnews.com